id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2003-D-0145-0005,FDA,FDA-2003-D-0145,Guidance,Supporting & Related Material,GDL-Guidance,2004-10-05T04:00:00Z,2004,10,,,2008-04-12T00:54:39Z,,0,0,0900006480486b3e
FDA-2003-D-0145-0007,FDA,FDA-2003-D-0145,FDA,Notice,NAD-Notice of Availability of Data,2004-10-05T04:00:00Z,2004,10,2004-10-04T04:00:00Z,2005-10-05T03:59:59Z,2008-04-12T00:54:38Z,,0,0,0900006480486b44
FDA-2003-D-0145-0004,FDA,FDA-2003-D-0145,Sterile Drug Products Produced by Aseptic Processing -- Current Good Manufacturing Practice,Other,Guidance,2004-10-05T04:00:00Z,2004,10,,,2025-09-17T09:01:12Z,,1,0,0900006480486b3a
FDA-2003-D-0145-0006,FDA,FDA-2003-D-0145,Guidance,Supporting & Related Material,GDL-Guidance,2004-10-05T04:00:00Z,2004,10,,,2008-04-12T00:54:37Z,,0,0,0900006480486b40
FDA-2003-D-0145-0001,FDA,FDA-2003-D-0145,FDA,Notice,NAD-Notice of Availability of Data,2003-09-22T04:00:00Z,2003,9,2003-09-04T04:00:00Z,2003-11-05T04:59:59Z,2008-04-12T00:54:38Z,,0,0,090000648048696f
FDA-2003-D-0145-0003,FDA,FDA-2003-D-0145,Draft Guidance,Supporting & Related Material,GDL-Guidance,2003-09-22T04:00:00Z,2003,9,,,2008-04-12T00:54:38Z,,0,0,09000064804869d3
FDA-2003-D-0145-0002,FDA,FDA-2003-D-0145,Draft Guidance,Supporting & Related Material,GDL-Guidance,2003-09-22T04:00:00Z,2003,9,,,2008-04-12T00:54:37Z,,0,0,09000064804869c0